Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 284

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Ticagrelor binds to human P2Y12 independently from ADP but antagonizes ADP‐induced receptor signaling and platelet aggregation

Open access
VAN GIEZEN, J.J.J., NILSSON, L., BERNTSSON, P., WISSING, B.M., GIORDANETTO, F., TOMLINSON, W., GREASLEY, P.J.·2009·Journal of Thrombosis and Haemostasis

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1538-7836.2009.03527.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 25

  1. Presland, 2005, Identifying novel modulators of G protein‐coupled receptors via interaction at allosteric sites, Curr Opin Drug Discov Devel, 8, 567
  2. Langmead, 2006, Allosteric agonists of 7TM receptors: expanding the pharmacological toolbox, Trends Pharmacol Sci, 27, 475, 10.1016/j.tips.2006.07.009 · DOI
  3. Gao, 2005, Allosteric modulation of the adenosine family of receptors, Mini-Rev Med Chem, 5, 545, 10.2174/1389557054023242 · DOI
  4. Holzgrabe, 2006, Allosteric modulators and selective agonists of muscarinic receptors, J Mol Neurosci, 30, 165, 10.1385/JMN:30:1:165 · DOI
  5. Maksay, 2005, Allosteric modulation of 5‐HT3 serotonin receptors, Eur J Pharmacol, 514, 17, 10.1016/j.ejphar.2005.03.019 · doi:10.1016/j.ejphar.2005.03.019
  6. Price, 2005, Allosteric modulation of the cannabinoid CB1 receptor, Mol Pharmacol, 68, 1484, 10.1124/mol.105.016162 · DOI · Paper page
  7. Gao, 2004, 2,2′‐Pyridylisatogen tosylate antagonizes P2Y1 receptor signaling without affecting nucleotide binding, Biochem Pharmacol, 68, 231, 10.1016/j.bcp.2004.02.039 · DOI
  8. Gaarder, 1961, Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets, Nature, 192, 531, 10.1038/192531a0 · DOI · Paper page
  9. Fagura, 1998, P2Y1‐receptors in human platelets which are pharmacologically distinct from P2YADP‐receptors, Br J Pharmacol, 124, 157, 10.1038/sj.bjp.0701827 · doi:10.1038/sj.bjp.0701827
  10. Hollopeter, 2001, Identification of the platelet ADP receptor targeted by antithrombotic drugs, Nature, 409, 202, 10.1038/35051599 · DOI · Paper page
  11. Takasaki, 2001, Molecular cloning of the platelet P2T(AC) ADP receptor: pharmacological comparison with another ADP receptor, the P2Y(1) receptor, Mol Pharmacol, 60, 432, 10.1016/S0026-895X(24)12604-1 · DOI
  12. Cattaneo, 2007, Platelet P2 receptors: old and new targets for antithrombotic drugs, Expert Rev Cardiovasc Ther, 5, 45, 10.1586/14779072.5.1.45 · DOI
  13. Van Giezen, 2005, Preclinical and clinical studies with selective reversible direct P2Y12 antagonists, Semin Thromb Hemost, 31, 195, 10.1055/s-2005-869525 · DOI · Paper page
  14. Springthorpe, 2007, From ATP to AZD6140: the discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosis, Bioorg Med Chem Lett, 17, 6013, 10.1016/j.bmcl.2007.07.057 · DOI · Paper page
  15. Van Giezen, 2008, Optimizing platelet inhibition, Eur Heart J Suppl, 10, D23, 10.1093/eurheartj/sun009 · doi:10.1093/eurheartj/sun009
  16. Husted, 2006, Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double‐blind comparison to clopidogrel with aspirin, Eur Heart J, 27, 1038, 10.1093/eurheartj/ehi754 · DOI · Paper page
  17. Cannon, 2007, Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non‐ST segment elevation acute coronary syndrome, J Am Coll Cardiol, 50, 1844, 10.1016/j.jacc.2007.07.053 · DOI · Paper page
  18. Van Giezen, 2008, AZD6140 displays over 100‐fold higher affinity for the P2Y12 receptor vs AZ11702105, a compound indistinguishable from the active metabolite of prasugrel, and is a more potent inhibitor of ADP‐induced platelet aggregation, Arterioscler Thromb Vasc Biol, 28, e139
  19. Sali, 1993, Comparative protein modelling by satisfaction of spatial restraints, J Mol Biol, 234, 779, 10.1006/jmbi.1993.1626 · DOI · Paper page
  20. McMartin, 1997, QXP: powerful, rapid computer algorithms for structure‐based drug design, J Comput Aided Mol Des, 11, 333, 10.1023/A:1007907728892 · DOI · Paper page
  21. Mills, 1992, Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase, Arterioscler Thromb, 12, 430, 10.1161/01.ATV.12.4.430 · doi:10.1161/01.atv.12.4.430
  22. Savi, 2006, The active metabolite of clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid rafts, Proc Natl Acad Sci USA, 103, 11069, 10.1073/pnas.0510446103 · DOI · Paper page
  23. Marteau, 2003, Pharmacological characterization of the human P2Y13 receptor, Mol Pharmacol, 64, 104, 10.1124/mol.64.1.104 · DOI · Paper page
  24. Ferguson, 2008, 2‐Aminothienopyridazines as novel adenosine A1 receptor allosteric modulators and antagonists, J Med Chem, 51, 6165, 10.1021/jm800557d · DOI
  25. Storey, 2007, Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes, J Am Coll Cardiol, 50, 1852, 10.1016/j.jacc.2007.07.058 · DOI · Paper page

Cited by

See all 284

Metadata

Authors
VAN GIEZEN, J. J. J., NILSSON, L., BERNTSSON, P., WISSING, B. M., GIORDANETTO, F., TOMLINSON, W., & GREASLEY, P. J.
Venue
Journal of Thrombosis and Haemostasis
Publisher
Elsevier BV
Published
2009-09
Volume
7
Issue
9
Pages
1556-1565
ISSN
1538-7836 (ISSN-L)
OpenAlex
W2069561061
Cited by
284
References
1
FWCI
12.85
Type
journal article
Language
en
Open access
bronze
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Ticagrelor binds to human P2Y12 independently from ADP but antagonizes ADP‐induced receptor signaling and platelet aggregation. https://app.cochat.ai/papers/10.1111/j.1538-7836.2009.03527.x
The paper
VAN GIEZEN, J. J. J., NILSSON, L., BERNTSSON, P., WISSING, B. M., GIORDANETTO, F., TOMLINSON, W., & GREASLEY, P. J. (2009). Ticagrelor binds to human P2Y12 independently from ADP but antagonizes ADP‐induced receptor signaling and platelet aggregation. Journal of Thrombosis and Haemostasis. https://doi.org/10.1111/j.1538-7836.2009.03527.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.